Provided by Tiger Trade Technology Pte. Ltd.

Cogent Biosciences, Inc.

36.73
+1.424.02%
Post-market: 36.33-0.4015-1.09%19:30 EDT
Volume:2.52M
Turnover:92.18M
Market Cap:6.37B
PE:-17.00
High:37.22
Open:35.75
Low:35.40
Close:35.31
52wk High:43.73
52wk Low:11.60
Shares:173.52M
Float Shares:166.83M
Volume Ratio:1.75
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1600
EPS(LYR):-2.5504
ROE:-109.74%
ROA:-43.84%
PB:13.63
PE(LYR):-14.40

Loading ...

Has Cogent Biosciences (COGT) Run Too Far After Wider Losses?

Simply Wall St.
·
Aug 17

Why Cogent Biosciences (COGT) Is Down 10.5% After Reporting Wider First-Half 2026 Losses – And What's Next

Simply Wall St.
·
Aug 16

Cogent Biosciences, Inc. : Leerink Partners Cuts Target Price to $60 from $72

THOMSON REUTERS
·
Aug 12

Wedbush Reaffirms Their Buy Rating on Cogent Biosciences (COGT)

TIPRANKS
·
Aug 11

Cogent Biosciences, Inc. : Guggenheim Raises Target Price to $52 from $45

THOMSON REUTERS
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Cogent Biosciences Files for USD 400 Million At-the-Market Stock Offering

Reuters
·
Aug 11

Cogent Biosciences - May Offer up to $400 Mln in Common Stock Through Guggenheim Securities - SEC Filing

THOMSON REUTERS
·
Aug 11

Sana Biotechnology Q2 Adjusted Loss Narrows, Beats Estimates

Reuters
·
Aug 11

Bionano Genomics Q2 Revenue Rises on Increased Clinical Adoption

Reuters
·
Aug 11

Cell Therapy Developer ProKidney's Q2 Operating Loss Widens as Trial Costs Rise

Reuters
·
Aug 11

Metagenomi Q2 Net Loss Widens Cash Runway Seen Through 2027

Reuters
·
Aug 11

Harrow Q2 Revenue Slightly Beats Estimates

Reuters
·
Aug 11

Rocket Pharmaceuticals Posts Q2 Profit Helped by PRV Sale

Reuters
·
Aug 11

Olema Pharmaceuticals Q2 Net Loss Widens on Higher Clinical Trial Spending

Reuters
·
Aug 11

Biohaven Q2 Net Loss Narrows on Lower R&D Spend

Reuters
·
Aug 11

Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership

Reuters
·
Aug 11

Cogent Biosciences Q2 Loss Widens

MT Newswires Live
·
Aug 10

Earnings Flash (COGT) Cogent Biosciences Posts Q2 Net Loss $96.4M, vs. FactSet Est of $98M Loss

MT Newswires Live
·
Aug 10

Cogent Biosciences Q2 Net Income USD -96.405 Million

Reuters
·
Aug 10